Ambrose Kristen, SVP and Chief Accounting Officer at Vertex Pharmaceuticals ($VRTX), sold nearly $2 million in company shares across five open market transactions over the past year. Her most recent sale occurred on February 26, 2026. These sales rank 3,522nd among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. Kristen made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 357 | $483.36 | 6,624.0000 | 258,000,000 | 5.11% | 0.00% |
| Feb. 25, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 223 | $486.35 | 6,981.0000 | 258,000,000 | 3.10% | 0.00% |
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 546 | $485.11 | 7,204.0000 | 258,000,000 | 7.05% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 598 | $483.75 | 9,945.0000 | 258,000,000 | 5.67% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 1809 | $0.00 | 10,543.0000 | 258,000,000 | 20.71% | 0.00% |
| Feb. 18, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 638 | $473.68 | 7,750.0000 | 258,000,000 | 7.61% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 1557 | $489.46 | 8,388.0000 | 258,000,000 | 15.66% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 1393 | $487.76 | 8,734.0000 | 258,000,000 | 13.76% | 0.00% |
| Feb. 11, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 1376 | $460.43 | 10,127.0000 | 258,000,000 | 11.96% | 0.00% |
| Feb. 10, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 592 | $468.41 | 11,503.0000 | 258,000,000 | 4.89% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 1300 | $0.00 | 12,095.0000 | 258,000,000 | 12.04% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 2950 | $0.00 | 10,795.0000 | 258,000,000 | 37.60% | 0.00% |
| Feb. 26, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 1241 | $479.61 | 7,845.0000 | 257,899,999 | 13.66% | 0.00% |
| Feb. 25, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 884 | $480.95 | 9,086.0000 | 257,899,999 | 8.87% | 0.00% |
| Feb. 24, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 828 | $483.28 | 9,970.0000 | 257,899,999 | 7.67% | 0.00% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 564 | $463.46 | 11,469.0000 | 257,899,999 | 4.69% | 0.00% |
| Feb. 18, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 671 | $455.06 | 10,798.0000 | 257,899,999 | 5.85% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 2080 | $0.00 | 12,033.0000 | 257,899,999 | 20.90% | 0.00% |
| Feb. 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 591 | $467.98 | 11,329.0000 | 257,899,999 | 4.96% | 0.00% |
| Feb. 11, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 1376 | $459.83 | 9,953.0000 | 257,899,999 | 12.15% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 1854 | $0.00 | 11,920.0000 | 257,899,999 | 18.42% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 2566 | $0.00 | 10,066.0000 | 257,899,999 | 34.21% | 0.00% |
| April 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 225 | $418.10 | 7,740.0000 | 260,500,000 | 2.82% | 0.00% |
| April 2, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 240 | $419.00 | 7,500.0000 | 260,500,000 | 3.10% | 0.00% |
| Feb. 26, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 883 | $425.70 | 7,965.0000 | 260,500,000 | 9.98% | 0.00% |
| Feb. 23, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 828 | $431.79 | 8,848.0000 | 260,500,000 | 8.56% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | F | Common Stock | 591 | $422.74 | 11,050.0000 | 260,500,000 | 5.08% | 0.00% |
| Feb. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | S | Common Stock | 1374 | $420.24 | 9,676.0000 | 260,500,000 | 12.43% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 1853 | $0.00 | 11,641.0000 | 260,500,000 | 18.93% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Ambrose Kristen | SVP & Chief Accounting Officer | A | Common Stock | 2950 | $0.00 | 9,788.0000 | 260,500,000 | 43.14% | 0.00% |